Pharmaceutical companies have managed their business in much the same way for decades. But significant changes in government regulations, market conditions, and technology will force the industry to look for new business models and practices. Companies that don't adapt face an uncertain and unsettling future.
Friday, September 11, 2015
Crohn's Disease - Pipeline Review, H1 2015
. http://asthmareview.wordpress.com DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/l6pzmr/crohns_disease)
has announced the addition of the "Crohn s
Disease - Pipeline Review, H1 2015" report to their offering.
This report provides comprehensive information on the therapeutic
development for Crohn s Disease, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. About Zyprexa (Olanzapine) without prescription It also
reviews key players involved in the therapeutic development for Crohn s
Disease and special features on late-stage and discontinued projects.
the report features investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000 indications. Buy Avodart (Dutasteride) with no Rx The report is built
using data and information sourced from the proprietary databases,
Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and
industry-specific third party sources, put together by the team. Buy Aceon (Perindopril) without Rx Drug
profiles/records featured in the report undergoes periodic updation
following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Femodene with free Rx Additionally,
processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. About Malegra FXT (Sildenafil/Fluoxetine) It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Companies Mentioned
Partial list of the 70+ companies mentioned in this comprehensive report:
4SC
AB Science
Baliopharm
BIOCAD
Calypso Biotech
Celgene
Daiichi Sankyo
DBV Technologies
Effimune
Eisai
Farmacija d.o.o. Buy Cell Volumizers online Tuzla
Ferring International Center
Galapagos
Genentech
iCo Therapeutics
Idera Pharmaceuticals
Johnson & Johnson
Kyorin Pharmaceutical
Mabion
Mesoblast
Neovacs
Oncobiologics
Oncodesign
Pfenex
Pfizer
Qu Biologics
Receptos
Sandoz International
Selexys Pharmaceuticals
Takeda Pharmaceutical Company
Teva Pharmaceutical Industries
Virobay
Winston Pharmaceuticals
For more information visit .researchandmarkets.com/research/l6pzmr/crohns_disease
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment